Results 181 to 190 of about 21,545 (230)

Multisystemic manifestations of a rare Glu89Lys (p. Glu109Lys) transthyretin amyloidosis: a case report of an East Asian female. [PDF]

BMC Neurol
Huang L, Zhou H, Chen J, Fang T, Lin Q.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transthyretin Cardiac Amyloidosis

Current Cardiology Reports, 2017
Transthyretin (TTR)-related cardiac amyloidosis is a progressive infiltrative cardiomyopathy that mimics hypertensive, hypertrophic heart disease and may go undiagnosed. Transthyretin-derived amyloidosis accounts for 18% of all cases of cardiac amyloidosis.
Anit K, Mankad, Keyur B, Shah
openaire   +2 more sources

Cardiac transthyretin amyloidosis

Heart, 2012
Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative cardiomyopathy characterised by ventricular wall thickening and diastolic heart failure. Increased access to cardiovascular magnetic resonance imaging has led to a marked increase in referrals to our centre of Caucasian patients with wild-type ATTR (senile systemic ...
Jason N, Dungu, Lisa J, Anderson, Carol J, Whelan, Philip N, Hawkins   +3 more
openaire   +2 more sources

Clusterin regulates transthyretin amyloidosis

Biochemical and Biophysical Research Communications, 2009
Transthyretin (TTR) is a human disease-associated amyloidogenic protein that has been implicated in senile systemic amyloidosis (SSA) and familial amyloidotic polyneuropathy (FAP). FAP typically results in severe and early-onset disease, and the only therapy established so far is liver transplantation; thus, developing new strategies for treating FAP ...
Ko-Woon, Lee, Dong-Hoon, Lee, Hosun, Son, Yoon-Sook, Kim, Jae-Yong, Park, Gu-Seob, Roh, Hyun-Joon, Kim, Sang-Soo, Kang, Gyeong-Jae, Cho, Wan-Sung, Choi   +9 more
openaire   +2 more sources

Hereditary transthyretin-related amyloidosis

Acta Neurologica Scandinavica, 2018
Hereditary transthyretin(TTR)-related amyloidosis (ATTRm amyloidosis) is an endemic/non-endemic, autosomal-dominant, early- and late-onset, rare, progressive disorder, predominantly manifesting as length-dependent, small fiber dominant, axonal polyneuropathy and frequently associated with cardiac disorders and other multisystem diseases.
Josef Finsterer, Stephan Iglseder, Julia Wanschitz, Raffi Topakian, Wolfgang N. Löscher, Wolfgang Grisold   +5 more
openaire   +2 more sources

Emerging Therapies for Transthyretin Amyloidosis

Current Oncology Reports, 2023
This review provides an overview of the available therapies for treating neuropathic and/or cardiac manifestations of transthyretin amyloidosis (ATTR), as well as investigational therapeutic agents in ongoing clinical trials. We discuss additional emergent approaches towards thwarting this life-threatening disease that until recently was considered ...
Melissa R. Tsoi, Jeffrey H. Lin, Ayan R. Patel   +2 more
openaire   +2 more sources